Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Amin, Nikhil" or (type any "bookEditor issueEditor" and editor="Amin, Nikhil")

Add to list
- Journal Article
- A1
Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui and Asif H. Khan (UGent)

(2023) ALLERGY.
Add to list
- Journal Article
- A1
- open access
Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps

Asif H. Khan (UGent) , Matthew Reaney, Isabelle Guillemin, Lauren Nelson, Shanshan Qin, Siddhesh Kamat, Leda Mannent, Nikhil Amin, Diane Whalley and Claire Hopkins

(2022) LARYNGOSCOPE. 132(5). p.933-941
Add to list
- Journal Article
- A1
- open access
Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Chien‐Chia Chuang, Isabelle Guillemin, Claus Bachert (UGent) , Stella E. Lee, Peter Hellings (UGent) , Wytske J. Fokkens, Nicolas Duverger, Chunpeng Fan, Nadia Daizadeh, Nikhil Amin, et al.

(2022) LARYNGOSCOPE. 132(2). p.259-264
Add to list
- Journal Article
- A1
- open access
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert (UGent) , Leda P. Mannent, G. Walter Canonica, Joseph K. Han, Jorge F. Maspero, Cesar Picado, Nadia Daizadeh, Benjamin Ortiz, et al.

(2022) ALLERGY. 77(4). p.1231-1244
Add to list
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim Mullol, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Philippe Gevaert (UGent) , Nadia Daizadeh, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(4). p.1086-1095.e5
Add to list
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

G Walter Canonica, Arnaud Bourdin, Anju T Peters, Martin Desrosiers, Claus Bachert (UGent) , Stephan Weidinger, Eric L Simpson, Nadia Daizadeh, Zhen Chen, Siddesh Kamat, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(6). p.1515-1526
Add to list
- Journal Article
- A1
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Michael E Wechsler, Linda B Ford, Jorge F Maspero, Ian D Pavord, Alberto Papi, Arnaud Bourdin, Henrik Watz, Mario Castro, Natalia M Nenasheva, Yuji Tohda, et al.

(2022) LANCET RESPIRATORY MEDICINE. 10(1). p.11-25
Add to list
- Journal Article
- A1
- open access
Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab

Asif H Khan, Adeline Abbe, Bruno Falissard, Paulo Carita, Claus Bachert (UGent) , Joaquim Mullol, Matthew Reaney, Jingdong Chao, Leda P Mannent, Nikhil Amin, et al.

(2021) PATIENT PREFERENCE AND ADHERENCE. 15. p.2577-2586
Add to list
- Conference Paper
- C3
Dupilumab treatment leads to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflafmmation

Ian Pavord, William Busse, Elliot Israel, Stanley Szefler, Zhen Chen, Nadia Daizadeh, David Lederer, Leda Mannent, Nikhil Amin, Elizabeth Laws, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(supplement 2). p.AB4-AB4

Academic Bibliography

Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps

Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps

Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab

Dupilumab treatment leads to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflafmmation

Contents

Support

Contact